In this episode, Shikha Jain, MD, speaks with Revolution Medicines’ Alan Sandler, MD, about groundbreaking advancements with daraxonrasib and how these findings will continue to impact metastatic pancreatic cancer.
Listen More
June 25, 2026
21 min listen
Receive an email when new episodes are posted on
Please provide your email address to receive an email when new episodes are posted on .
Suneel Kamath, MD, knows too well the sense of helplessness that comes with living through what he calls “the doughnut…
In this episode, recorded live at ASCO Annual Meeting, host Shikha Jain, MD, speaks with W. Kimryn Rathmell, MD, PhD, about the…
CHICAGO — The eagerly awaited full dataset from arguably the most pivotal pancreatic cancer trial in decades is now public.Based…
Highly anticipated data presented at ASCO confirmed what’s been heralded as a medical breakthrough against a historically…
The eagerly awaited full dataset from the most pivotal pancreatic cancer study in decades didn’t just live up to expectations.It…
In a special “woman on the street” episode, host Hansa Bhargava, MD, is live at ASCO 2026. She meets with oncology innovators to…
